[1] Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–5.
[2] Blaser MJ. Helicobacter pylori and gastric diseases. BMJ. 1998;316(7143):1507–10.
[3] International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 61. Lyon: IARC; 1994.
[4] Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20(10):1161–81.
[5] Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc. 1994;40(3):342–5.
[6] El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney system. Hum Pathol. 1999;30(1):72–7.
[7] Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF. Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000;53(10):756–9.
[8] Jonkers D, Stobberingh E. Diagnosis of Helicobacter pylori infection. BMJ. 1999;319(7215):278–80.
[9] McNulty CA, Wise R. Rapid diagnosis of Campylobacter pylori infection. Lancet. 1985;1(8436):1443–4.
[10] Genta RM. The immunohistochemical diagnosis of Helicobacter pylori. Hum Pathol. 1996;27(2):134–40.
[11] El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY. The utility of immunohistochemistry in the diagnosis of Helicobacter pylori infection. Hum Pathol. 1998;29(6):596–601.
[12] Hartman DJ, Owens SR. Are routine ancillary stains required to diagnose Helicobacter pylori gastritis? Am J Clin Pathol. 2012;137(2):255–60.
[13] Kocsmár É, Szirtes I, Kramer Z, et al. Sensitivity of Helicobacter pylori detection methods in gastric biopsies. World J Gastroenterol. 2017;23(24):4473–82.
[14] Rugge M, Meggio A, Pravadelli C, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56(5):631–6.
[15] Owens SR, Greenson JK. The pathology of Helicobacter pylori gastritis. Histopathology. 2007;50(2):193–203.
[16] Chey WD, Wong BCY. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808–25.
[17] Laine L, Cohen H, Sloane R, Marin-Sorensen M, Weinstein WM. Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis. Gastroenterology. 1995;108(3):708–14.
[18] Stolte M, Bethke B. Elimination of Helicobacter pylori under proton pump inhibitors. Z Gastroenterol. 1990;28(6):271–4.
[19] Meining A, Bayerdörffer E, Müller P, Stolte M. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Gastroenterology. 1998;114(6):1351–7.
[20] Shukla S, Pujani M, Agarwal A, Pujani M, Rohtagi A. Correlation of histopathological features of chronic gastritis with Helicobacter pylori infection. Indian J Pathol Microbiol. 2012;55(3):321–4.
[21] Akeel M, Elhafey A, Shehata A, Elmakki E, Aboshouk T, Ageely H, et al. Efficacy of immunohistochemical staining in detecting Helicobacter pylori in patients with minimal and atypical infection. Eur J Histochem. 2021;65(3):3183.
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications